Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for DSSTox_CID_3342 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    DSSTox_CID_3342

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 806Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 EUROAPI
    France
    		 EUROAPI GERMANY GmbH Frankfurt am Main DE R1-CEP 2010-058 - Rev 02 Nadolol 2021-12-10 Valid Chemical 1789
    26/09/2024 Biophore India Pharmaceuticals Pvt Ltd
    India
    		 BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad IN CEP 2017-209 - Rev 02 Nadolol 2024-07-16 Valid Chemical 1789